ID   RIFK_HUMAN              Reviewed;         155 AA.
AC   Q969G6; Q5JSG9; Q9NUT7;
DT   03-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   14-OCT-2008, sequence version 2.
DT   04-FEB-2015, entry version 128.
DE   RecName: Full=Riboflavin kinase;
DE            EC=2.7.1.26;
DE   AltName: Full=ATP:riboflavin 5'-phosphotransferase;
DE   AltName: Full=Flavokinase;
GN   Name=RFK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, INTERACTION WITH CYBA; TNFRSF1A AND TRADD, AND MUTAGENESIS
RP   OF GLU-79.
RX   PubMed=19641494; DOI=10.1038/nature08206;
RA   Yazdanpanah B., Wiegmann K., Tchikov V., Krut O., Pongratz C.,
RA   Schramm M., Kleinridders A., Wunderlich T., Kashkar H.,
RA   Utermoehlen O., Bruening J.C., Schuetze S., Kroenke M.;
RT   "Riboflavin kinase couples TNF receptor 1 to NADPH oxidase.";
RL   Nature 460:1159-1163(2009).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 2-148 IN COMPLEX WITH MG-ADP
RP   AND RIBOFLAVIN NUCLEOTIDE.
RX   PubMed=12623014; DOI=10.1016/S0969-2126(03)00024-8;
RA   Karthikeyan S., Zhou Q., Mseeh F., Grishin N.V., Osterman A.L.,
RA   Zhang H.;
RT   "Crystal structure of human riboflavin kinase reveals a beta barrel
RT   fold and a novel active site arch.";
RL   Structure 11:265-273(2003).
CC   -!- FUNCTION: Catalyzes the phosphorylation of riboflavin (vitamin B2)
CC       to form flavin-mononucleotide (FMN), hence rate-limiting enzyme in
CC       the synthesis of FAD. Essential for TNF-induced reactive oxygen
CC       species (ROS) production. Through its interaction with both
CC       TNFRSF1A and CYBA, physically and functionally couples TNFRSF1A to
CC       NADPH oxidase. TNF-activation of RFK may enhance the incorporation
CC       of FAD in NADPH oxidase, a critical step for the assembly and
CC       activation of NADPH oxidase. {ECO:0000269|PubMed:19641494}.
CC   -!- CATALYTIC ACTIVITY: ATP + riboflavin = ADP + FMN.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC       Note=Zinc or magnesium.;
CC   -!- PATHWAY: Cofactor biosynthesis; FMN biosynthesis; FMN from
CC       riboflavin (ATP route): step 1/1.
CC   -!- SUBUNIT: Monomer. Directly interacts with TNFRSF1A death domain.
CC       TNFRSF1A-binding may be supported by TRADD. In the absence of
CC       TNFRSF1A, interacts with TRADD. Independently of TNFRSF1A,
CC       interacts with the NADPH oxidase subunit CYBA.
CC       {ECO:0000269|PubMed:12623014, ECO:0000269|PubMed:19641494}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Detected in brain, placenta and urinary
CC       bladder.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH07069.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAA92033.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK002011; BAA92033.1; ALT_INIT; mRNA.
DR   EMBL; AL391868; CAI40676.1; -; Genomic_DNA.
DR   EMBL; BC007069; AAH07069.1; ALT_INIT; mRNA.
DR   CCDS; CCDS35044.2; -.
DR   RefSeq; NP_060809.3; NM_018339.5.
DR   UniGene; Hs.37558; -.
DR   PDB; 1NB0; X-ray; 1.70 A; A=2-148.
DR   PDB; 1NB9; X-ray; 1.70 A; A=2-148.
DR   PDB; 1P4M; X-ray; 1.80 A; A=2-148.
DR   PDB; 1Q9S; X-ray; 2.42 A; A=1-148.
DR   PDBsum; 1NB0; -.
DR   PDBsum; 1NB9; -.
DR   PDBsum; 1P4M; -.
DR   PDBsum; 1Q9S; -.
DR   ProteinModelPortal; Q969G6; -.
DR   SMR; Q969G6; 2-148.
DR   BioGrid; 120594; 3.
DR   DIP; DIP-60454N; -.
DR   IntAct; Q969G6; 3.
DR   MINT; MINT-1401441; -.
DR   STRING; 9606.ENSP00000257452; -.
DR   DrugBank; DB00140; Riboflavin.
DR   PhosphoSite; Q969G6; -.
DR   DMDM; 209572667; -.
DR   MaxQB; Q969G6; -.
DR   PaxDb; Q969G6; -.
DR   PRIDE; Q969G6; -.
DR   DNASU; 55312; -.
DR   Ensembl; ENST00000376736; ENSP00000365926; ENSG00000135002.
DR   GeneID; 55312; -.
DR   KEGG; hsa:55312; -.
DR   UCSC; uc004akd.2; human.
DR   CTD; 55312; -.
DR   GeneCards; GC09M079000; -.
DR   H-InvDB; HIX0169330; -.
DR   HGNC; HGNC:30324; RFK.
DR   HPA; HPA057163; -.
DR   MIM; 613010; gene.
DR   neXtProt; NX_Q969G6; -.
DR   PharmGKB; PA134916697; -.
DR   eggNOG; COG0196; -.
DR   GeneTree; ENSGT00390000015537; -.
DR   HOGENOM; HOG000260803; -.
DR   HOVERGEN; HBG049989; -.
DR   InParanoid; Q969G6; -.
DR   KO; K00861; -.
DR   OMA; NNTERSA; -.
DR   OrthoDB; EOG7K3TP0; -.
DR   PhylomeDB; Q969G6; -.
DR   TreeFam; TF313786; -.
DR   BioCyc; MetaCyc:HS05938-MONOMER; -.
DR   Reactome; REACT_11070; Vitamin B2 (riboflavin) metabolism.
DR   UniPathway; UPA00276; UER00406.
DR   ChiTaRS; RFK; human.
DR   EvolutionaryTrace; Q969G6; -.
DR   GenomeRNAi; 55312; -.
DR   NextBio; 59546; -.
DR   PRO; PR:Q969G6; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; Q969G6; -.
DR   CleanEx; HS_RFK; -.
DR   ExpressionAtlas; Q969G6; baseline and differential.
DR   Genevestigator; Q969G6; -.
DR   GO; GO:0005737; C:cytoplasm; NAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008531; F:riboflavin kinase activity; NAS:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IMP:MGI.
DR   GO; GO:0009398; P:FMN biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0033864; P:positive regulation of NAD(P)H oxidase activity; IMP:MGI.
DR   GO; GO:0072593; P:reactive oxygen species metabolic process; IEA:Ensembl.
DR   GO; GO:0009231; P:riboflavin biosynthetic process; NAS:UniProtKB.
DR   GO; GO:0006771; P:riboflavin metabolic process; TAS:Reactome.
DR   GO; GO:0044281; P:small molecule metabolic process; TAS:Reactome.
DR   GO; GO:0006766; P:vitamin metabolic process; TAS:Reactome.
DR   GO; GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome.
DR   Gene3D; 2.40.30.30; -; 1.
DR   InterPro; IPR023468; Riboflavin_kinase.
DR   InterPro; IPR015865; Riboflavin_kinase_bac/euk.
DR   InterPro; IPR023465; Riboflavin_kinase_domain.
DR   PANTHER; PTHR22749; PTHR22749; 1.
DR   Pfam; PF01687; Flavokinase; 1.
DR   SMART; SM00904; Flavokinase; 1.
DR   SUPFAM; SSF82114; SSF82114; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; Cytoplasm; Flavoprotein;
KW   FMN; Kinase; Magnesium; Metal-binding; Nucleotide-binding;
KW   Reference proteome; Transferase; Zinc.
FT   CHAIN         1    155       Riboflavin kinase.
FT                                /FTId=PRO_0000194148.
FT   ACT_SITE     79     79       Nucleophile. {ECO:0000250}.
FT   METAL        27     27       Magnesium.
FT   BINDING      15     15       ATP; via amide nitrogen.
FT   BINDING      21     21       ATP; via amide nitrogen.
FT   BINDING      27     27       ATP; via amide nitrogen.
FT   BINDING      29     29       ATP.
FT   BINDING      82     82       ATP; via amide nitrogen and carbonyl
FT                                oxygen.
FT   BINDING      84     84       ATP; via carbonyl oxygen.
FT   BINDING      91     91       ATP.
FT   BINDING     104    104       FMN.
FT   BINDING     107    107       FMN; via amide nitrogen and carbonyl
FT                                oxygen.
FT   BINDING     109    109       FMN; via amide nitrogen.
FT   MUTAGEN      79     79       E->Q: Loss of kinase activity. No effect
FT                                on TNFRSF1A- and CYBA-binding.
FT                                {ECO:0000269|PubMed:19641494}.
FT   CONFLICT     96     96       N -> S (in Ref. 1; BAA92033).
FT                                {ECO:0000305}.
FT   STRAND        5     11       {ECO:0000244|PDB:1NB9}.
FT   STRAND       16     18       {ECO:0000244|PDB:1NB9}.
FT   HELIX        20     23       {ECO:0000244|PDB:1NB9}.
FT   HELIX        32     36       {ECO:0000244|PDB:1NB9}.
FT   STRAND       44     53       {ECO:0000244|PDB:1NB9}.
FT   STRAND       59     67       {ECO:0000244|PDB:1NB9}.
FT   STRAND       71     73       {ECO:0000244|PDB:1NB9}.
FT   STRAND       76     84       {ECO:0000244|PDB:1NB9}.
FT   STRAND       93    104       {ECO:0000244|PDB:1NB9}.
FT   HELIX       112    129       {ECO:0000244|PDB:1NB9}.
FT   HELIX       133    136       {ECO:0000244|PDB:1NB9}.
FT   HELIX       137    140       {ECO:0000244|PDB:1NB9}.
FT   HELIX       142    145       {ECO:0000244|PDB:1NB9}.
SQ   SEQUENCE   155 AA;  17623 MW;  3E038E487E164EBA CRC64;
     MRHLPYFCRG QVVRGFGRGS KQLGIPTANF PEQVVDNLPA DISTGIYYGW ASVGSGDVHK
     MVVSIGWNPY YKNTKKSMET HIMHTFKEDF YGEILNVAIV GYLRPEKNFD SLESLISAIQ
     GDIEEAKKRL ELPEHLKIKE DNFFQVSKSK IMNGH
//
